Qingwang Liu

551 total citations
24 papers, 255 citations indexed

About

Qingwang Liu is a scholar working on Molecular Biology, Hematology and Pharmacology. According to data from OpenAlex, Qingwang Liu has authored 24 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Pharmacology. Recurrent topics in Qingwang Liu's work include Chronic Myeloid Leukemia Treatments (5 papers), Ginseng Biological Effects and Applications (3 papers) and Biological and pharmacological studies of plants (3 papers). Qingwang Liu is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Ginseng Biological Effects and Applications (3 papers) and Biological and pharmacological studies of plants (3 papers). Qingwang Liu collaborates with scholars based in China and United States. Qingwang Liu's co-authors include Xijing Chen, Han Xing, Qingsong Liu, Di Zhao, Wei Yang, Shuqin Li, Ruisen Lin, Xingen Hu, Yuanwei Jia and Jing Liu and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Molecules.

In The Last Decade

Qingwang Liu

23 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingwang Liu China	11	102	70	41	35	28	24	255
Fen Wei China	14	205 2.0×	52 0.7×	31 0.8×	35 1.0×	68 2.4×	26	426
Tatsunari Yoshida Japan	12	316 3.1×	13 0.2×	30 0.7×	12 0.3×	9 0.3×	15	625
Rohmad Yudi Utomo Indonesia	11	169 1.7×	77 1.1×	49 1.2×	37 1.1×	29 1.0×	46	357
Neha Choudhary Canada	11	63 0.6×	18 0.3×	28 0.7×	25 0.7×	42 1.5×	22	328
Steven B. Zhang United States	8	119 1.2×	31 0.4×	43 1.0×	59 1.7×	25 0.9×	14	376
Tinggui Chen China	11	175 1.7×	47 0.7×	31 0.8×	85 2.4×	21 0.8×	21	402
Bharat Goel India	11	162 1.6×	35 0.5×	76 1.9×	32 0.9×	36 1.3×	38	344
Robert T. Streeper United States	8	118 1.2×	55 0.8×	40 1.0×	99 2.8×	32 1.1×	21	333
Qinghua Jiang China	12	132 1.3×	27 0.4×	24 0.6×	40 1.1×	50 1.8×	27	304

Countries citing papers authored by Qingwang Liu

Since Specialization

Citations

This map shows the geographic impact of Qingwang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingwang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingwang Liu more than expected).

Fields of papers citing papers by Qingwang Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingwang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingwang Liu. The network helps show where Qingwang Liu may publish in the future.

Co-authorship network of co-authors of Qingwang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingwang Liu. A scholar is included among the top collaborators of Qingwang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingwang Liu. Qingwang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xixiang, Hongwei Yu, Fengming Zou, et al.. (2025). Discovery of a 1 H -Pyrazol-3-Amine Derivative as a Novel, Selective, and Orally Available RIPK1 Inhibitor for the Treatment of Inflammatory Disease. Journal of Medicinal Chemistry. 68(20). 21766–21785. 1 indexed citations

Sun, Yongqiang, Yongping Zhang, Anqi Wei, et al.. (2024). Mixed Systems of Quaternary Ammonium Foam Drainage Agent with Carbon Quantum Dots and Silica Nanoparticles for Improved Gas Field Performance. Nanomaterials. 14(19). 1590–1590.

Li, Minghui, Fengge Wang, Wenjie Zhang, et al.. (2024). Anti-atherosclerotic effect of tetrahydroxy stilbene glucoside via dual-targeting of hepatic lipid metabolisms and aortic M2 macrophage polarization in ApoE-/- mice. Journal of Pharmaceutical and Biomedical Analysis. 248. 116338–116338. 2 indexed citations

Wang, Junjie, Ziping Qi, Yun Wu, et al.. (2023). Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus. Signal Transduction and Targeted Therapy. 8(1). 143–143. 12 indexed citations

Liang, Huamin, Fengming Zou, Liyi Fu, et al.. (2022). PEG-Bottlebrush Stabilizer-Based Worm-like Nanocrystal Micelles with Long-Circulating and Controlled Release for Delivery of a BCR-ABL Inhibitor against Chronic Myeloid Leukemia (CML). Pharmaceutics. 14(8). 1662–1662. 2 indexed citations

Liu, Qingwang, et al.. (2022). Identification and characterization of the metabolites of moscatilin in mouse, rat, dog, monkey and human hepatocytes by LC–Orbitrap–MS/MS combined with diagnostic fragment ions and accurate mass measurements. Biomedical Chromatography. 37(4). e5573–e5573. 4 indexed citations

Liang, Xiaofei, Beilei Wang, Juan Liu, et al.. (2022). Discovery of Pyrrolo[2,3-d]pyrimidine derivatives as potent and selective colony stimulating factor 1 receptor kinase inhibitors. European Journal of Medicinal Chemistry. 243. 114782–114782. 7 indexed citations

Xing, Han, et al.. (2021). In Vitro and In Vivo Studies of Metabolic Activation of Marrubiin, a Bioactive Constituent from Marrubium Vulgare. Chemical Research in Toxicology. 34(9). 2157–2165. 2 indexed citations

Lu, Tingting, Fengming Zou, Xixiang Li, et al.. (2021). Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML). European Journal of Pharmacology. 897. 173944–173944. 8 indexed citations

10.

Liu, Qingwang, et al.. (2021). A validated UHPLC–MS/MS method for simultaneous determination of lumiracoxib and its hydroxylation and acyl glucuronidation metabolites in rat plasma: Application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 201. 114105–114105. 2 indexed citations

11.

Chen, Hao, Jia Chen, Weidong Chen, et al.. (2021). Characterization of the metabolite of cabozantinib generated from liver microsomes and hepatocytes by ultra-high performance liquid chromatography coupled to quadrupole/orbitrap high resolution mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 205. 114343–114343. 1 indexed citations

12.

Fu, Liyi, Fengming Zou, Qingwang Liu, et al.. (2020). An ultra-long circulating nanoparticle for reviving a highly selective BCR-ABL inhibitor in long-term effective and safe treatment of chronic myeloid leukemia. Nanomedicine Nanotechnology Biology and Medicine. 29. 102283–102283. 4 indexed citations

13.

Liu, Xuesong, Beilei Wang, Cheng Chen, et al.. (2019). Discovery of (E)-N¹-(3-Fluorophenyl)-N³-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)malonamide (CHMFL-KIT-033) as a Novel c-KIT T670I Mutant Selective Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs). Journal of Medicinal Chemistry. 62(10). 5006–5024. 16 indexed citations

14.

Liang, Xiaofei, Zongru Jiang, Zhenghui Huang, et al.. (2019). Discovery of 6′-chloro-N-methyl-5’-(phenylsulfonamido)-[3,3′-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium. European Journal of Medicinal Chemistry. 188. 112012–112012. 16 indexed citations

15.

Wu, Yun, Beilei Wang, Junjie Wang, et al.. (2019). Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of c-KIT Kinase for Gastrointestinal Stromal Tumors. Journal of Medicinal Chemistry. 62(13). 6083–6101. 13 indexed citations

16.

Jia, Yuanwei, Xin Li, Haitang Xie, et al.. (2014). Analysis and pharmacokinetics studies of gastrodin and p-hydroxybenzyl alcohol in dogs using ultra fast liquid chromatography–tandem mass spectrometry method. Journal of Pharmaceutical and Biomedical Analysis. 99. 83–88. 26 indexed citations

17.

Zhao, Jie, Yanli Wen, Wei Zhang, et al.. (2014). Investigation on pharmacokinetics, tissue distribution and excretion of a novel platinum anticancer agent in rats by Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Xenobiotica. 44(8). 757–762. 10 indexed citations

18.

Jia, Yuanwei, Jie Shen, Haitang Xie, et al.. (2014). Identification and analysis of gastrodin and its five metabolites using ultra fast liquid chromatography electrospray ionization tandem mass spectrometry to investigate influence of multiple-dose and food. Journal of Chromatography A. 1358. 110–116. 18 indexed citations

19.

Zhao, Di, et al.. (2014). Pharmacokinetics, Tissue Distribution, Excretion and Plasma Protein Binding Studies of Wogonin in Rats. Molecules. 19(5). 5538–5549. 52 indexed citations

20.

Zhang, Yongjie, Di Zhao, Jie Xu, et al.. (2013). Effects of Dietary Factors on the Pharmacokinetics of 58Fe-labeled Hemin After Oral Administration in Normal Rats and the Iron-deficient Rats. Biological Trace Element Research. 153(1-3). 243–250. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact